Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prof. Tomris Ozben of Turkey Elected Next President of the IFCC

By LabMedica International staff writers
Posted on 04 Oct 2022

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) has announced the election of Prof. More...

Tomris Ozben, representing the Turkish Biochemical Society (TBS), as its next President. In the election, Prof. Ozben received 45 votes (58%) from the 77 member societies that voted, out of a total of 89 member societies. Her term in office starts on January 2023 and is scheduled to end on December 2026. Other candidates in the election were Prof. Michael Neumaier (German Society for Clinical Chemistry and Laboratory Medicine; DGKL) and Prof. Tahir Pillay (South African Association for Clinical Biochemistry and Laboratory Medicine; SAACB).

Prof. Ozben, EuSpLM, Ph.D., D.Sc., and Specialist in Clinical Biochemistry, currently serves as President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). She has been Chair or a Member in many Federations, Scientific Organizations, Societies, Committees and Councils. She is the Past-IFCC Treasurer, Past-Chair of the IFCC Congress and Conference Committee, Past-President of the Balkan Clinical Laboratory Federation (BCLF), and Board Member of the IFCC Foundation for Emerging Nations (FEN).

Over her tenure at Akdeniz University (Antalya, Turkey), Prof. Ozben has served as Vice Rector, Director of Research Funds, Chair of the Dept. of Clinical Biochemistry, and Founding Director of Central Laboratory at Akdeniz University Hospital. She worked for more than 10 years in the Ethical Committee of Akdeniz University Hospital and Medical Faculty on themes concerning drug research in clinical trials. She served as Commission Member of the Turkish Ministry of Health for restructuring Medical Education and Teaching, as well as Member-Elect of the Turkish High Educational Council for four years.

Prof. Ozben’s own research interests include identification of early markers for diagnosis and prognosis of cancer, cardiovascular and chronic kidney diseases, diabetes, liquid biopsy, proteomics, oxidative stress and antioxidants in health and disease, impact of apoptosis in cancer therapy, multidrug resistance, nanoparticles, therapeutic drug monitoring, development and validation of new tests, analytical techniques, quality control and management, teaching, mentoring, research, and laboratory management.

Prof. Ozben serves as mentor to numerous graduate students and takes part at Post-Graduate Education Programs (Specialty and PhD) at Akdeniz University, PhD program “Clinical Experimental Medicine” at University of Modena and Reggio Emilia and External Examiner for Post-graduate education at University of Zimbabwe. She has received several awards including Akdeniz University “Outstanding Service” and “Science” awards, AACC Van Slyke Society and AACC TDM/Toxicology Division and AACC’s National Academy of Clinical Biochemistry (NACB) awards.

Prof. Ozben is on the Editorial Board of several scientific journals, and a reviewer for several journals, and scientific projects evaluator for the Italian Ministry for University Education and Research (MIUR; CINECA), Ministry of Science and Environmental Protection of Republic of Serbia, Israel Science Foundation, and the Scientific and Technological Research Council of Turkey (TUBITAK). She has taken part in the organization of several WorldLabs, EuroMedLabs, IFCC General Conference, and FEBS-IUBMB Advanced Courses, Workshops and Young Scientists FORUMs. She has published over 250 manuscripts; several book chapters; edited books published by international publishers, and attended as an invited speaker to more than 300 international conferences.

Related Links:
IFCC 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.